(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CVS HEALTH CLINICAL TRIAL SERVICES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CVS HEALTH CLINICAL TRIAL SERVICES

ST13

US500000090527326

Class

35, 42

Filing

90527326

Registration

7115912

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

07/18/2023

Trademark type

Word

Nice classes

35, 42

Filing date

02/12/2021

Registration date

07/18/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/18/2023

Last transaction

07/18/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2021-01-00

First use in commerce

2021-01-00

Drawing code

4

Owner type

03

Owner location

Woonsocket, RI, US

Examiner

RINKER, ANTHONY MICHAEL

Law office

L20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

CVS Pharmacy, Inc.

Representatives

Erich G. Rhynhart

Technical classification

Nice Classes

Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Medical personnel and subject recruitment services for clinical trial studies; Conducting pre and post market study surveillance in the field of medical and scientific clinical trials

Class 42

Medical and scientific researchclinical trial services for others and conducting clinical trials for others; Pharmaceutical and vaccine research and development services; Testing of pharmaceuticals and vaccines; Pharmaceutical and vaccine drug development services; Medical research services relating to pharmaceuticals and vaccines; Providing medical and scientific research information in the fields of pharmaceuticals and vaccines; Medical and scientific researchproviding analysis of data obtained from clinical trial studies

Publications

History of USPTO decisions and trademark events.

28 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/18/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

07/18/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

06/13/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/12/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/09/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/08/2023

IUAF

USE AMENDMENT FILED

04/20/2023

EISU

TEAS STATEMENT OF USE RECEIVED

04/20/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/21/2022

EX1G

SOU EXTENSION 1 GRANTED

10/19/2022

EXT1

SOU EXTENSION 1 FILED

10/19/2022

EEXT

SOU TEAS EXTENSION RECEIVED

10/19/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/10/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/15/2022

PUBO

PUBLISHED FOR OPPOSITION

03/15/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/23/2022

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/04/2022

ALIE

ASSIGNED TO LIE

02/04/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/03/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/03/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/03/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/03/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/18/2021

GNRT

NON-FINAL ACTION E-MAILED

08/18/2021

CNRT

NON-FINAL ACTION WRITTEN

08/18/2021

DOCK

ASSIGNED TO EXAMINER

08/18/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/17/2021

NWAP

NEW APPLICATION ENTERED

02/16/2021

Continuous trademark protection

Get notified about every new filing that threatens CVS HEALTH CLINICAL TRIAL SERVICES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.